MAPT and Parkinson disease: The results indicated that PD patients with worse kidney function had lower levels of CSF Aβ1-42 and α-syn, as well as higher levels of serum NfL at baseline, while they had greater accumulation of CSF T-tau, P-tau, and serum NfL at 7-year follow-up.